About gempex
gempex GmbH is an independent, international service provider specialising in consultancy and the implementation of GMP requirements in the life science industry. Headquartered in Mannheim, Germany, gempex also has sites in Sisseln, Switzerland and Guangzhou, China.
The company was founded in 2002 with a team of 15 experts. Today more than 60 employees provide support for the implementation, optimisation and maintenance of quality assurance systems around the world. Customers include leading companies in the chemical and pharmaceutical industries, biotechnology, cosmetics and medical devices as well as their suppliers. Services focus on consultancy and project implementation for GMP compliance, commissioning & qualification, IT validation and GMP routines. The range of services extends from the initial analysis to the development and realisation of concepts to Expert Leasing.
Customers value the full range of services offered by gempex and the proven expertise in the field of “Good Practices” (such as GMP, GSP and GDP) and comparable quality assurance systems.
Advertisement
Product portfolio of gempex
Here you will find gempex GmbH
Last viewed contents
Artificial intelligence is drastically changing the healthcare sector - Companies are engaging with AI and investing in it, but only 29 percent feel well prepared to use GenAI for competitive advantage
Malaria Parasites Move on Right-Handed Helices - Motion patterns help the transition between tissue compartments
Coriolis Pharma Research GmbH - Martinsried, Germany
Rentschler Biopharma SE - Laupheim, Germany
Novozymes Biopharma Signs License Agreement with GE Healthcare to Produce and Sell Protein A
Biotech has Positive Year Despite Weak Fourth Quarter Performance - Burrill looks back at 2007
Nanoscale ruler reveals organization of the cell membrane - Freiburg biologists measure distances and the arrangement of membrane molecules in nanometer range
Australia’s Top 20 cancer drugs to reach sales of $1 billion by 2018
Tripos to Build One of the Leading Informatics-Driven Drug Discovery Laboratories in Europe - - State-of-the-Art Chemical Synthesis Facilities to be Built in Cornwall, England -
5 Leading Multinationals Announce R&D Projects for Ireland - Bristol-Myers Squibb Company, Pfizer Inc., Genzyme Corporation, Xilinx Inc. Citigroup are investing a total of EUR 53.25 million
Pesticides and other common chemical pollutants are toxic to our ‘good’ gut bacteria
